Therefore, one of the important methods to treat tumours is to use molecular targets in the PI3K-Akt signalling pathway for rational drug designing.[14] Cyclin D1 mainly regulates the transition of the cell cycle from the G1 to S phase. This evidence concerns the gene AKT1 and neoplasm.